TransDigm Group INC
For the period ended Dec 28, 2024. Filed Feb 4, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Dec 28, 2024 · Filed Feb 4, 2025
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2024-06-29; filed 2024-08-06.
0001260221-24-000069
Item 1A. RISK FACTORSCurrent report: 10-Q
Period ended 2024-12-28; filed 2025-02-04.
0001260221-25-000014
Item 1A. RISK FACTORSThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 3 previous paragraphs and 2 current paragraphs.
1 unchanged; 0 reworded; 1 added; 2 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 0 previous and 2 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
The current filing states there were no material changes to risk factors.
This is the filer’s own statement, not a conclusion from the comparison. Read its qualifications and the report it references.
Current filing’s statement
In addition to the other information set forth in this report, you should carefully consider the risk factors disclosed in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended September 30, 2024, filed on November 7, 2024. There have been no material changes to the risk factors described in the Form 10-K.
Added paragraphs (1)
Current report
The following table presents information about repurchases of TransDigm Group Inc. common stock made by us during the first quarter of fiscal year 2025 (in millions, except shares and average price per share data):
Removed paragraphs (2)
Previous report
On January 27, 2022, the Board of Directors of the Company authorized a new stock repurchase program to permit repurchases of its outstanding common stock not to exceed $2,200 million in the aggregate (the “$2,200 million stock repurchase program”), replacing the $650 million stock repurchase program previously authorized by the Board on November 8, 2017, subject to any restrictions specifiedin the Second Amended and Restated Credit Agreement dated as of June 4, 2014, and/or Indentures governing the Company's existing Notes. There is no expiration date for this program.
Previous report
No repurchases were made under the program in thethirty-nine week period ended June 29, 2024. As of June 29, 2024, $1,288 million remains available for repurchase under the $2,200 million stock repurchase program.